Therapeutic potential of small interfering RNA for central nervous system diseases

Amy E. Lovett-Racke, Petra D. Cravens, Anne R. Gocke, Michael K. Racke, Olaf Stüve

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations


RNA interference (RNAi) is an evolutionarily conserved mechanism to degrade messenger RNA (mRNA) that has sequence homology to small double-stranded RNA (dsRNA). It is believed that the normal biological function of RNAi is to protect the host cells from RNA viruses and transposons, which can jeopardize the genome. Production of dsRNA in the host cell signals a series of events that ultimately results in the degradation of complementary mRNA. Recently, small interfering RNA (siRNA) has been used to study the function and significance of a vast number of genes in a variety of cell types. In the future, siRNA may have tremendous potential as gene-specific therapeutic agents for the treatment of many diseases. We discuss the potential role of siRNA as a novel therapeutic strategy for several central nervous system (CNS) diseases.

Original languageEnglish (US)
Pages (from-to)1810-1813
Number of pages4
JournalArchives of neurology
Issue number12
StatePublished - Dec 2005

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Clinical Neurology


Dive into the research topics of 'Therapeutic potential of small interfering RNA for central nervous system diseases'. Together they form a unique fingerprint.

Cite this